5-HT1-like receptors requiring functional cyclo-oxygenase and 5-HT2 receptors independent of cyclo-oxygenase mediate contraction of the human umbilical artery

British Journal of Pharmacology
S J MacLennanJ C McGrath

Abstract

1. The interactions between 5-hydroxytryptamine (5-HT) and the antagonists ketanserin, methysergide and phentolamine were studied in isolated preparations of human umbilical artery (HUA) at physiological oxygen tension (Po2 approximately 15 mmHg) and at high PO2 (approximately 120 mmHg). 2. At physiological Po2 ketanserin, methysergide and phentolamine behaved as silent competitive antagonists of the 5-HT-induced contraction of HUA. pA2 values calculated by Schild analysis were 8.92, 8.52 and 6.37, respectively. 3. At high Po2, 5-HT-induced contractions were antagonised in a biphasic manner by ketanserin (0.1 microM); the response to low but not to high concentrations of 5-HT was resistant to blockade by ketanserin. The ketanserin-resistant component was abolished following cyclo-oxygenase inhibition by indomethacin (1 microM). 4. At high Po2, methysergide behaved as a partial agonist. Methysergide-induced contractions were inhibited but not abolished by indomethacin, and resistant to 5-HT2 receptor and alpha 1-adrenoceptor blockade. 5. At high Po2 the component of the response to 5-HT mediated by the ketanserin-resistant receptor was mimicked by the selective 5-HT1-like receptor agonist 5-carboxamidotryptamine (5-CT): 5-CT was...Continue Reading

References

Oct 1, 1976·British Journal of Pharmacology·E ApperleyG P Levy
Sep 1, 1977·Prostaglandins·J SvenssenM Hamberg
Feb 1, 1976·European Journal of Pharmacology·V A Alabaster, Y S Bakhle
Jan 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·M Frenken, A J Kaumann
Mar 15, 1988·European Journal of Pharmacology·B Kokkas, J M Boeynaems
Jan 1, 1988·Journal of Receptor Research·D Hoyer
Nov 1, 1986·The Journal of Physiology·J C McGrathM J Whittle
Sep 1, 1986·British Journal of Pharmacology·J R Docherty, L Hyland
Jul 30, 1982·European Journal of Pharmacology·R M Brazenor, J A Angus
Aug 1, 1982·The Journal of Pharmacy and Pharmacology·P P HumphreyA D Watts
Sep 1, 1980·Journal of Cardiovascular Pharmacology·E Müller-Schweinitzer
Dec 9, 1983·European Journal of Pharmacology·W FeniukA D Watts
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Dec 1, 1962·British Journal of Pharmacology and Chemotherapy·I R INNES
Jan 1, 1964·American Journal of Obstetrics and Gynecology·H WULF
Sep 1, 1946·American Journal of Obstetrics and Gynecology·M SPIVACK

❮ Previous
Next ❯

Citations

Oct 20, 1992·European Journal of Pharmacology·M S Fernández-AlfonsoJ Marín
Feb 9, 1993·European Journal of Pharmacology·M J Van DiestA G Herman
Aug 25, 1995·European Journal of Pharmacology·G Bodelsson, M Stjernquist
May 1, 1996·Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology·M Ishizawa
Feb 1, 1991·British Journal of Pharmacology·I Sahin-ErdemliP Schoeffter
Feb 1, 1992·British Journal of Pharmacology·J M SeagerC J Garland
Oct 6, 2009·Reproductive Sciences·António José Santos-SilvaIgnacio Verde
May 5, 2018·The Journal of Obstetrics and Gynaecology Research·Margarida LorigoElisa Cairrao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.